NFKB1 and neoplasm: CRT also increases expression of intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 on tumour endothelial cells via nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activity, thereby improving anti-tumour immune responses [118,119].